Skip to Content
Merck

Epidermal growth factor receptor in tumor angiogenesis.

Hematology/oncology clinics of North America (2004-10-12)
Lee M Ellis
PMID15474332
ABSTRACT

This article focuses on the preclinical evidence for activation of the epidermal growth factor receptor (EGFR) in promoting angiogenesis and the efficacy of anti-EGFR agents in inhibiting angiogenesis and tumor growth.